dc.contributor.author | Dřevínek, Pavel | |
dc.contributor.author | Canton, Rafael | |
dc.contributor.author | Johansen, Helle Krogh | |
dc.contributor.author | Hoffman, Lucas | |
dc.contributor.author | Coenye, Tom | |
dc.contributor.author | Burgel, Pierre-Regis | |
dc.contributor.author | Davies, Jane C | |
dc.date.issued | 2022 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/1651 | |
dc.description.abstract | In this review, we summarize the main points that were raised and highlighted during the pre-conference meeting to the 17(th) European Cystic Fibrosis Society Basic Science Conference, held from 30 March to 2 April, 2022 in Albufeira, Portugal. Keynote lectures provided an update on the latest information regarding the phenomenon of antimicrobial resistance (AMR) in cystic fibrosis (CF). Traditional themes such as in vitro antibiotic susceptibility testing and its clinical value, AMR evolution in persistent Pseudomonas aeruginosa infection and the impact of biofilm on AMR were discussed. In addition, the report gives an overview on very recent AMR-related topics that include an ecological view of AMR in CF lung, referred to as resistome, and novel anti-infective approaches in preclinical or early clinical research such as antibiofilm drugs and bacteriophages. | en |
dc.language.iso | en | |
dc.relation.url | https://doi.org/10.1016/j.jcf.2022.10.005 | |
dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.title | New concepts in antimicrobial resistance in cystic fibrosis respiratory infections | en |
dcterms.accessRights | openAccess | |
dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
dc.date.updated | 2023-12-20T15:10:44Z | |
dc.subject.keyword | Antimicrobial resistance | en |
dc.subject.keyword | Antimicrobial strategies | en |
dc.subject.keyword | Antimicrobial susceptibility testing | en |
dc.subject.keyword | Biofilm | en |
dc.subject.keyword | Pathoadaptation | en |
dc.subject.keyword | Resistome | en |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/FN/I-FN/I-FNM | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/UK/COOP/COOP | |
dc.date.embargoStartDate | 2023-12-20 | |
dc.type.obd | 73 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dc.identifier.doi | 10.1016/j.jcf.2022.10.005 | |
dc.identifier.utWos | 000928202100007 | |
dc.identifier.eidScopus | 2-s2.0-85140054898 | |
dc.identifier.obd | 616655 | |
dc.identifier.riv | RIV/00216208:11130/22:10448996 | |
dc.identifier.riv | RIV/00064203:_____/22:10448996 | |
dc.identifier.pubmed | 36270946 | |
dc.subject.rivPrimary | 30000::30300::30303 | |
dcterms.isPartOf.name | Journal of Cystic Fibrosis | |
dcterms.isPartOf.issn | 1569-1993 | |
dcterms.isPartOf.journalYear | 2022 | |
dcterms.isPartOf.journalVolume | 21 | |
dcterms.isPartOf.journalIssue | 6 | |
uk.faculty.primaryId | 109 | |
uk.faculty.primaryName | 2. lékařská fakulta | cs |
uk.faculty.primaryName | Second Faculty of Medicine | en |
uk.faculty.secondaryId | 52 | |
uk.faculty.secondaryName | Fakultní nemocnice v Motole | cs |
uk.faculty.secondaryName | Motol University Hospital | en |
uk.department.primaryId | 109 | |
uk.department.primaryName | 2. lékařská fakulta | cs |
uk.department.primaryName | Second Faculty of Medicine | en |
uk.department.secondaryId | 1701 | |
uk.department.secondaryId | 100010693902 | |
uk.department.secondaryName | Ústav lékařské mikrobiologie | cs |
uk.department.secondaryName | Ústav lékařské mikrobiologie | en |
uk.department.secondaryName | Ústav lékařské mikrobiologie 2. LF UK a FN Motol | cs |
uk.department.secondaryName | Department of Medical Microbiology, 2nd Faculty of Medicine and Motol University Hospital | en |
dc.description.pageRange | 937-945 | |
dc.type.obdHierarchyCs | ČLÁNEK V ČASOPISU::článek v časopisu::přehledový článek | cs |
dc.type.obdHierarchyEn | JOURNAL ARTICLE::journal article::summarizing article | en |
dc.type.obdHierarchyCode | 73::152::205 | en |
uk.displayTitle | New concepts in antimicrobial resistance in cystic fibrosis respiratory infections | en |